Real-world outcomes of ranibizumab in patients with retinal vein occlusion from the LUMINOUS™ study

被引：0
|
作者：
Pearce, Ian [1 ]
Parikh, Soumil [2 ]
Macfadden, Wayne [2 ]
机构：
[1] Royal Liverpool Univ Hosp, St Pauls Eye Unit, Liverpool, Merseyside, England
[2] Novartis Pharma AG, Basel, Switzerland
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2018年 / 59卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2566
引用
收藏
页数：6
相关论文
共 50 条
  • [31] Anatomical Outcomes of the BRAVO Study of Intravitreal Ranibizumab in Patients With Macular Edema Following Branch Retinal Vein Occlusion
    Bhisitkul, R. B.
    Gray, S.
    Murahashi, W. Yee
    Saroj, N. N.
    Rundle, A.
    Rubio, R.
    Chan, A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [32] Effect of Alternate Ranibizumab Dosing Regimens on Visual and Anatomic Outcomes in Patients with Retinal Vein Occlusion - The SHORE study
    Hariprasad, Seenu M.
    Yau, Linda
    Sternberg, Gary
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [33] Outcomes at 1 Year with Ranibizumab in Treatment-Naive Patients with Neovascular Age-Related Macular Degeneration: Real-World Results from the LUMINOUS Study
    Mitchell, Paul
    Macfadden, Wayne
    Lacey, Sue
    OPHTHALMOLOGICA, 2016, 236 : 1 - 1
  • [34] Treatment outcomes with anti-VEGF therapy for retinal vein occlusion: an analysis of real-world data from 16 UK sites
    Dinah, Christiana
    Dodds, Melanie
    Arrisi, Pablo
    Pereira, Liliana Paris
    Lake, Alice
    Nielsen, Patrick
    Holdsworth, John
    Saffar, Insaf
    Chi, Gloria
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [35] Factors associated with visual outcomes and treatment discontinuation in eyes with retinal vein occlusion and macular edema in real-world settings
    Lo, Therlinder
    Lent-Schochet, Daniella
    Luu, Kieu-Yen
    Kuriyan, Ajay E.
    Weiss, Menachem Y.
    Rachitskaya, Aleksandra
    Singh, Rishi P.
    Wai, Karen Michelle
    Campbell, J. Peter
    Gupta, Kishan
    Nudleman, Eric
    Chen, Kevin C.
    Yiu, Glenn
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [36] Clinical trial versus real-world outcomes with anti-VEGF therapy for branch and central retinal vein occlusion
    Danzig, Carl J.
    Blotner, Steven
    Steffen, Verena
    Haskova, Zdenka
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [37] Comparing the efficacy of bevacizumab to ranibizumab in patients with retinal vein occlusion. The BRVO study
    Vader, M. J. C.
    Schauwvlieghe, A. M. E.
    Verbraak, F. D.
    Dijkman, G.
    Hooymans, J. M. M.
    Los, L. I.
    Zwinderman, A. H.
    Peto, T.
    Hoyng, C. B.
    van Leeuwen, R.
    Vingerling, J. R.
    de Jong-Hesse, Y.
    van Lith-Verhoeven, J. J. C.
    Dijkgraaf, M. G. W.
    Schlingemann, R. O.
    ACTA OPHTHALMOLOGICA, 2019, 97 : 39 - 40
  • [38] Treatment outcome of switching from ranibizumab to aflibercept in patients with central retinal vein occlusion
    Konidaris, V.
    Gorgoli, K.
    Burgula, S.
    Deane, J.
    Banerjee, S.
    Empeslidis, T.
    ACTA OPHTHALMOLOGICA, 2016, 94
  • [39] RANIBIZUMAB FOR RETINAL VEIN OCCLUSION Predictive Factors and Long-Term Outcomes in Real-Life Data
    Chatziralli, Irini
    Theodossiadis, George
    Chatzirallis, Alexandros
    Parikakis, Efstratios
    Mitropoulos, Panagiotis
    Theodossiadis, Panagiotis
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 (03): : 559 - 568
  • [40] Impact of Intravitreal Ranibizumab on Vessel Functionality in Patients With Retinal Vein Occlusion
    Corvi, Federico
    La Spina, Carlo
    Benatti, Lucia
    Querques, Lea
    Lattanzio, Rosangela
    Bandello, Francesco
    Querques, Giuseppe
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2015, 160 (01) : 45 - 52
12345